Rapid Novor Inc.

Rapid Novor is a contract research organization specializing in antibody protein characterization and discovery services. The company offers a comprehensive suite of capabilities including:

Antibody Discovery & Development

• Nanobody discovery
• Human antibody discovery
• Anti-idiotype antibody discovery
• Custom antibody development
• Recombinant antibody expression

Protein Sequencing & Analysis

• De novo protein sequencing
• Antibody sequencing
• Polyclonal antibody sequencing
• Peptide mapping and analysis
• Intact mass analysis of antibodies
• Glycan analysis
• Post-translational modification (PTM) analysis
• Disulfide bond analysis
• Drug antibody ratio (DAR) analysis

Functional Characterization

• HDX-MS epitope mapping
• Surface plasmon resonance (SPR) for antibody-antigen interaction analysis

Applications Rapid Novor supports clients across multiple therapeutic areas and development stages, including antibody engineering, IP protection, hybridoma loss prevention, in vitro diagnostics, biologics drug discovery, target validation, gene and cell therapy development, cell line development, biosimilar development, and validation of AI-designed antibodies. The company also serves veterinary medicine and research applications.